Drug firms hype disease as sales ploy, industry chief claims

Ray Moynihan

doi:10.1136/bmj.324.7342.867

Drug firms hype disease as sales ploy, industry chief claims

Ray Moynihan^*

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Article › Professional

12 Citations (Scopus)

Abstract

A senior pharmaceutical company executive says estimates of the prevalence of diseases are often exaggerated.

Using the example of his company's promotion of “social phobia,” Fred Nadjarian, managing director of Roche in Australia, said: “The marketing people always beat [hype] these things up. It's just natural enthusiasm.”

Original language	English
Pages (from-to)	867-867
Number of pages	1
Journal	BMJ (Clinical research ed.)
Volume	324
Issue number	7342
DOIs	https://doi.org/10.1136/bmj.324.7342.867
Publication status	Published - 13 Apr 2002

Access to Document

10.1136/bmj.324.7342.867

Cite this

@article{513e0c0a063b4e1397cefe6b5ec1fafd,

title = "Drug firms hype disease as sales ploy, industry chief claims",

abstract = "A senior pharmaceutical company executive says estimates of the prevalence of diseases are often exaggerated. Using the example of his company's promotion of “social phobia,” Fred Nadjarian, managing director of Roche in Australia, said: “The marketing people always beat [hype] these things up. It's just natural enthusiasm.”",

author = "Ray Moynihan",

year = "2002",

month = apr,

day = "13",

doi = "10.1136/bmj.324.7342.867",

language = "English",

volume = "324",

pages = "867--867",

journal = "BMJ (Clinical research ed.)",

issn = "0959-535X",

publisher = "BMJ Publishing Group",

number = "7342",

}

TY - JOUR

T1 - Drug firms hype disease as sales ploy, industry chief claims

AU - Moynihan, Ray

PY - 2002/4/13

Y1 - 2002/4/13

N2 - A senior pharmaceutical company executive says estimates of the prevalence of diseases are often exaggerated. Using the example of his company's promotion of “social phobia,” Fred Nadjarian, managing director of Roche in Australia, said: “The marketing people always beat [hype] these things up. It's just natural enthusiasm.”

AB - A senior pharmaceutical company executive says estimates of the prevalence of diseases are often exaggerated. Using the example of his company's promotion of “social phobia,” Fred Nadjarian, managing director of Roche in Australia, said: “The marketing people always beat [hype] these things up. It's just natural enthusiasm.”

UR - https://www.scopus.com/pages/publications/19044385465

U2 - 10.1136/bmj.324.7342.867

DO - 10.1136/bmj.324.7342.867

M3 - Article

C2 - 11950722

AN - SCOPUS:19044385465

SN - 0959-535X

VL - 324

SP - 867

EP - 867

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

IS - 7342

ER -

Drug firms hype disease as sales ploy, industry chief claims

Abstract

Access to Document

Other files and links

Fingerprint

Cite this